Body Fluid Exposures 

  • Author: Nathalie Mathieu, MD; Chief Editor: Rick Kulkarni, MD   more...
 
Updated: Aug 25, 2010
 

Background

Occupational transmission of blood-borne infections may occur through parenteral, mucous membrane, and nonintact skin exposure. The greatest risk for transdermal transmission is via a skin penetration injury sustained with a sharp hollow-bore needle that was recently removed from a blood-contaminated source. Although many infections may be transmitted by such contact, the most consequential are hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV). In addition, skin and soft tissue infection at the site of the inoculation, through introduction of staphylococcal species, is an issue of concern and must not be neglected. Tetanus prophylaxis is also an important issue of concern. Another important concept is the fact that many clinical pathways adopt plans for management primarily of health care personnel but are woefully lacking when faced with the outside individual at risk for significant exposure.

A flowsheet for management of body fluid exposure is shown below.

Flowsheet for management of blood/body fluid exposFlowsheet for management of blood/body fluid exposures.
Next

Pathophysiology

When intact, the integumentary system serves as an effective physical barrier to the entry of infectious elements into the body. However, a special situation exists in terms of mucous membranes. Across these membranes, lies a layer of mucus secreted by specialized columnar cells that are closely associated with each other through gap junctions, which are little more than specialized cell surface projections that allow intercellular communication. The presence of a moist mucous layer tends to prolong the viability of fragile viruses, such as HIV and HBV, which cannot survive long in drier environments. However, HBV has been demonstrated to survive on countertops for 7 days and remain capable of causing infection,[1] while HCV has been shown to be able to survive on environmental surfaces for a minimum of 16 hours but not for 4 days.[2]

Higher vascularity coupled with a relatively permeable cellular layer gives rise to a presumed heightened risk of transmission of HBV, HCV, and HIV across this organ system and into the bloodstream. Still, at least for occupational HIV exposures, transmission rarely occurs. Intact, keratinized skin does not possess these characteristics and is virtually impermeable unless disrupted. After initial exposure, animal models have shown that HIV replicates within dendritic cells of the skin and mucosa within the first 48 hours before spreading through lymphatic vessels and becoming a systemic infection. This time lapse from initial introduction of the virus to systemic spread allows an opportunity to inhibit the replication of the virus using postexposure prophylaxis.[3]

In terms of blood and body fluids, semen and vaginal secretions with visible blood should be considered potentially infectious vehicles. Similarly, cerebrospinal fluid, amniotic fluid, pleural fluid, synovial fluid, and peritoneal and pericardial fluids carry a high suspicion of risk for transmission. In addition, unless blood is present, saliva, sputum, sweat, tears, feces, nasal secretions, urine, and vomitus carry a low risk of transmission of HBV, HCV, and HIV.

Previous
Next

Epidemiology

Frequency

United States

Sharps injuries occur at a rate of 1.8 per year per physician and 0.98 per year per nurse while working on the same medical ward. Statistically, twice as many nurses as doctors have been reported with occupationally acquired HIV infection. Whether this is a functionality of the significance of the exposure (ie, severity of the stick) or the route of exposure remains to be studied.

The risk for developing HIV after a needlestick injury involving an HIV-infected patient is around 0.3%. Factors that increase the odds of HIV transmission after percutaneous exposure are depth of injury, visibility of blood on device, exposure from a needle that was in an artery or vein, and terminal illness in source patient.[4] Note that the risk of HIV transmission from exposure of HIV-infected fluids on the mucosa of health care workers was extremely low (0.09%) and that no cases HIV conversion after exposure of intact skin to HIV-contaminated fluids were reported.[5]

Following a needlestick, the risk of HCV is 3 times higher than that of HIV, while that of HBV ranges from 6-30%, depending on the presence of hepatitis B e antigen (HBeAg).[6]

In a retrospective study of first responders presenting to an ED for body fluid or blood exposure, the incidence was 23.29 ED visits per 100,000 ambulance runs.[7]

Mortality/Morbidity

Health care workers who have a significant exposure to HBV (ie, inoculation with an open-bore needle from a source known to have active HBV disease) but have not previously received hepatitis B vaccine and do not receive postexposure prophylaxis have a 6-30% risk of becoming infected.

The risk of HCV transmission from a known HCV-positive source by a sharps injury is 0-7%. Approximately 80% of those infected with HCV will develop active liver disease, 10-20% will develop cirrhosis, and 1-5% of cirrhosis cases will develop liver cancer over a period of years.[8]

The rate of HIV transmission from a known infected individual via a sharps injury is 0.3%, whereas that for exposure to mucous membrane is 0.09%.[9] The rate is higher if the injury was sustained by a hollow-bore needle, if the injury was deeply penetrating, or if blood was injected during injury. Risk to the injured health care worker is greater if the source patient has a high HIV viral load, lower CD4 count, or both.

Previous
 
 
Contributor Information and Disclosures
Author

Nathalie Mathieu, MD  Resident Physician, Department of Emergency Medicine, State University of New York Downstate Medical Center

Disclosure: Nothing to disclose.

Coauthor(s)

Joel R Gernsheimer, MD, FACEP  Visiting Associate Professor, Department of Emergency Medicine, Attending Physician and Director of Geriatric Emergency Medicine, State University of New York Downstate Medical Center

Joel R Gernsheimer, MD, FACEP is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Samuel M Keim, MD  Associate Professor, Department of Emergency Medicine, University of Arizona College of Medicine

Samuel M Keim, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Public Health Association, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Pharmacy Editor, eMedicine

Disclosure: Nothing to disclose.

Barry J Sheridan, DO  Chief, Department of Emergency Medical Services, Brooke Army Medical Center

Barry J Sheridan, DO is a member of the following medical societies: American Academy of Emergency Medicine

Disclosure: Nothing to disclose.

John D Halamka, MD, MS  Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center

John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Chief Editor

Rick Kulkarni, MD 

Rick Kulkarni, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: WebMD Salary Employment

References
  1. Simard EP, Miller JT, George PA, et al. Hepatitis B vaccination coverage levels among healthcare workers in the United States, 2002-2003. Infect Control Hosp Epidemiol. Jul 2007;28(7):783-90. [Medline]. [Full Text].

  2. Kamili S, Krawczynski K, McCaustland K, Li X, Alter MJ. Infectivity of hepatitis C virus in plasma after drying and storing at room temperature. Infect Control Hosp Epidemiol. May 2007;28(5):519-24. [Medline].

  3. van Tongeren M, Mee T, Whatmough P, Broad L, Maslanyj M, Allen S. Assessing occupational and domestic ELF magnetic field exposure in the uk adult brain tumour study: results of a feasibility study. Radiat Prot Dosimetry. 2004;108(3):227-36. [Medline]. [Full Text].

  4. New York State Department of Health AIDS Institute. Recommendations for HIV Postexposure Prophylaxis (PEP). 2008. Available at http://www.hivguidelines.org.

  5. Henderson DK, Fahey BJ, Willy M, Schmitt JM, Carey K, Koziol DE. Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures. A prospective evaluation. Ann Intern Med. Nov 15 1990;113(10):740-6. [Medline].

  6. [Guideline] Panlilio AL, Cardo DM, Grohskopf LA, Heneine W, Ross CS. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep. Sep 30 2005;54:1-17. [Medline].

  7. Merchant RC, Nettleton JE, Mayer KH, Becker BM. Blood or body fluid exposures and HIV postexposure prophylaxis utilization among first responders. Prehosp Emerg Care. Jan-Mar 2009;13(1):6-13. [Medline].

  8. National Institutes of health consensus development conference statement: management of hepatitis C. June 10-12, 2002. Available at http://consensus.nih.gov/2002/2002hepatitisc2002116html.htm.

  9. Landovitz RJ, Currier JS. Clinical practice. Postexposure prophylaxis for HIV infection. N Engl J Med. Oct 29 2009;361(18):1768-75. [Medline].

  10. [Guideline] Boyce JM, Pittet D. Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm Rep. Oct 25 2002;51:1-45, quiz CE1-4. [Medline].

  11. Mallin R, Sinclair D. Needlestick injuries and potential body fluid exposure in the emergency department. CJEM. Jan 2003;5(1):36-7. [Medline]. [Full Text].

  12. Nguyen CT, Tran TT. Hepatitis vaccination and prophylaxis. Clin Liver Dis. May 2009;13(2):317-29. [Medline].

  13. Alter MJ. Occupational exposure to hepatitis C virus: a dilemma. Infect Control Hosp Epidemiol. Dec 1994;15(12):742-4. [Medline].

  14. [Guideline] CDC. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers. MMWR Morb Mortal Wkly Rep. Jun 23 1989;38 Suppl 6:1-37. [Medline].

  15. [Guideline] CDC. Protection against viral hepatitis. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep. Feb 9 1990;39:1-26. [Medline].

  16. [Guideline] CDC. Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis. Centers for Disease Control and Prevention. MMWR Recomm Rep. May 15 1998;47:1-33. [Medline].

  17. Gerberding JL, Henderson DK. Management of occupational exposures to bloodborne pathogens: hepatitis B virus, hepatitis C virus, and human immunodeficiency virus. Clin Infect Dis. Jun 1992;14(6):1179-85. [Medline].

  18. Kiyosawa K, Sodeyama T, Tanaka E, et al. Hepatitis C in hospital employees with needlestick injuries. Ann Intern Med. Sep 1 1991;115(5):367-9. [Medline].

  19. Lanphear BP. Trends and patterns in the transmission of bloodborne pathogens to health care workers. Epidemiol Rev. 1994;16(2):437-50. [Medline].

  20. Marcus R. Surveillance of health care workers exposed to blood from patients infected with the human immunodeficiency virus. N Engl J Med. Oct 27 1988;319(17):1118-23. [Medline].

  21. Mast ST, Woolwine JD, Gerberding JL. Efficacy of gloves in reducing blood volumes transferred during simulated needlestick injury. J Infect Dis. Dec 1993;168(6):1589-92. [Medline].

  22. Mauskopf JA, Bradley CJ, French MT. Benefit-cost analysis of hepatitis B vaccine programs for occupationally exposed workers. J Occup Med. Jun 1991;33(6):691-8. [Medline].

  23. Merchant RC, Becker BM, Mayer KH, Fuerch J, Schreck B. Emergency department blood or body fluid exposure evaluations and HIV postexposure prophylaxis usage. Acad Emerg Med. Dec 2003;10(12):1345-53. [Medline].

  24. Jagger J. Risky procedures, risky devices, risky job. Adv in Exposure Prev. 1994;1:4-6.

  25. Robert LM, Bell DM. HIV transmission in the health-care setting. Risks to health-care workers and patients. Infect Dis Clin North Am. Jun 1994;8(2):319-29. [Medline].

  26. Stewardson DA, Burke FJ, Elkhazindar MM, et al. The incidence of occupational exposures among students in four UK dental schools. Int Dent J. Feb 2004;54(1):26-32. [Medline].

  27. Vu T. Standardization of Body Surface Area Calculations. 1999. halls.md. Available at http://www.halls.md/bsa/bsaVuReport.htm.

Previous
Next
 
Flowsheet for management of blood/body fluid exposures.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.